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This Month in the Journal
This month in the Journal, David Amor and Andy Choo
provide an overview of neocentromeres. Despite the ab-
sence of centromeric a-satellite DNA, neocentromeres
are able to assemble a functional kinetochore and func-
tion as de novo centromeres. The formation, composi-
tion, and consequences of neocentromere formation are
discussed, as are their potential roles in gene therapy
and in evolution.
Diallelic Indels, by Weber et al. (p. 854)
Weber et al. report the most comprehensive screen of
human diallelic insertion/deletion (indel) polymorphisms
to date, with 2,000 indels identified and characterized.
The identification of a large number of indel polymor-
phisms is likely to be valuable for gene-mapping studies,
and complete information on the indels described in this
work will be available online (for details, see the “Re-
sults” section of the paper). Indels were identified
through comparisons of overlapping human genomic or
cDNA sequences. Attempts were then made to confirm
the polymorphisms by amplifying the sequences from a
variety of human populations and from at least one great
ape sample. Approximately 58% of the candidate indels
were actually confirmed. Through comparisons with the
corresponding sequences from apes, it was found that
nearly all of the indels arose since the divergence of the
human, chimpanzee, and gorilla common ancestors and
that the monomorphic alleles in chimps and gorillas are
likely to represent the ancestral alleles. Examination of
the indel allele frequencies allows some speculation on
population histories. Whereas, in the African popula-
tions, newer indel alleles have a bias toward low allele
frequencies, the European, Japanese, and Native Amer-
ican populations have undergone population bottle-
necks, so there is less bias for new alleles to be at low
frequency.
Neuregulin 1 and Schizophrenia, by Stefansson et al.
(p. 877)
Starting with a sample of Icelandic individuals with
schizophrenia, Stefansson et al. used the powerful Ice-
landic genealogy database to generate large multiplex
pedigrees for use in a genomewide linkage scan that
identifies neuregulin 1 (NRG1) as a candidate gene for
schizophrenia risk. This gene is located on chromosome
8p, a region that has been identified in other linkage
studies for schizophrenia. A core risk haplotype that
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contains the first exon of NRG1 was identified in the
families, and it is estimated to increase the risk of schizo-
phrenia by 2.2-fold, compared to the wild-type hap-
lotype. Unfortunately, no obvious functional NRG1
variant could be identified. The role ofNRG1 in schizo-
phrenia is, however, supported by mouse models. Rep-
licating what was seen in another strain of NRG1 mu-
tant mice, Stefansson et al. found that mice heterozygous
for mutations inNRG1 or ErbB4 (a neuregulin receptor)
show hyperactivity that can be reversed by treatment
with the antipsychotic clozapine. The NRG1 hypo-
morphic mice also showed impaired prepulse inhibition
and a reduction in the number of functional N-methyl-
D-aspartate (NMDA) receptors, both features that have
been seen in schizophrenic humans. Although a conclu-
sive role for neuregulin in the development of schizo-
phrenia has not been demonstrated, NRG1 is an inter-
esting candidate gene for follow-up.
Y-Chromosome Palindromes and Massive Deletions,
by Repping et al. (p. 906)
Repping et al. have characterized AZFb and AZFb plus
AZFc deletions on the Y chromosome, and these turn
out to be some of the largest human interstitial deletions
for which the deletion junctions and intervening se-
quence are known. AZFb and AZFc are two of the three
regions on the Y chromosome that are essential for nor-
mal spermatogenesis, and the deletions in this studywere
found in men whose only obvious phenotype was azoos-
permia (absence of sperm in the semen). This is sur-
prising because of the number of genes (up to 42) re-
moved by the deletions, including a number that are
known to be expressed in tissues other than the testes.
Homologous recombination at breakpoint hotspots ap-
pears to be at the root of seven of the nine deletions
characterized in the study, but it does not appear to tell
the whole story. First, there are sequences adjacent to
the deletion breakpoints that have the same level of sim-
ilarity—and even longer segments of perfect identity—as
those involved in the deletions, yet they do not seem to
undergo homologous recombination. Second, there are
two deletion cases that cannot be explained by homol-
ogous recombination. The authors propose that factors
in addition to homology play a role in the deletion
mechanism.
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On the Twin Risk in Autism, by Hallmayer et al. (p.
941)
Increased Rate of Twins among Affected Sib Pairs, by
Visscher (p. 995)
In two recent papers, Greenberg et al. (Am J HumGenet
69:1062–1067) and Betancur et al. (Am J Hum Genet
70:1381–1383) found evidence that twinning may be a
risk factor contributing to autism. In these studies, an
excess of MZ twins (and DZ twins in the Greenberg et
al. study) was found in samples of affected sib pairs. In
this issue of the Journal, a letter to the editor by Peter
Visscher suggests that an excess of twin pairs, particu-
larly MZ twins, would be expected in a sample of af-
fected sib pairs if genetic factors contribute to the de-
velopment of the disorder of interest. Dr. Visscher
suggests that a population-based study may be a better
way to examine this issue, and Hodge et al., the authors
of the reply to this letter, concur. Lucky for us, Hallmayer
et al. performed a population-based study of autism in
western Australia. Their results do not suggest an excess
of autism among twins. Hallmayer et al. reason that the
high proportion of autistic twins found among affected
sib pairs is due to the high concordance rates in MZ
twins versus siblings and to fact that there is a higher
proportion of twins among families with two or more
children. Two other recent studies also present data on
the rates of twinning in autism. Hultman et al. and
Croen et al. (see citations in Hallmayer et al.) reported
population-based studies in Sweden and California, re-
spectively. Hultman et al. did not find a difference in
twinning rates between a sample of individuals with au-
tism and the general population. Croen et al. did find a
slight increase in twinning in their autism sample, al-
though a considerably smaller increase than those seen
by Greenberg et al. and Betancur et al.
RNASEL Mutation and Prostate Cancer in Ashkenazi
Jews, by Rennert et al. (p. 981)
Recent studies have reported evidence that variation in
RnaseL is associated with familial prostate cancer (see
Carpten et al. and Ro¨kman et al. references in Rennert
et al., as well as Wang et al. [Am J Hum Genet 71:
116–123]). Rennert et al. examined this gene in the Ash-
kenazi Jewish population and propose that they have
identified a founder mutation. They first identified the
novel 4-bp deletion, 471delAAAG, in an affected sib
pair. Tissue samples were available from one of the
brothers in this sib pair, and these were used to show
loss of heterozygosity for RNaseL in tumor tissue but
not in tissue with benign prostatic hyperplasia. The
471delAAAG mutation was found at slightly, but not
significantly, increased rates in unselected Ashkenazi
prostate cancer patients versus a group of Ashkenazi
women that served as a population control. Additional
population-based studies are required to determine the
role of 471delAAAG in risk of prostate cancer. However,
it is interesting that the 471delAAAG mutation is also
found in LNCaP cells, a commonly used human prostate
cancer cell line.
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